lidocaine has been researched along with antipyrine in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (40.74) | 18.7374 |
1990's | 6 (11.11) | 18.2507 |
2000's | 17 (31.48) | 29.6817 |
2010's | 9 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Caron, G; Ermondi, G | 1 |
Jolivette, LJ; Ward, KW | 1 |
Carrupt, PA; Martel, S; Ottaviani, G | 2 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Conradi, R; Lee, PH; Shanmugasundaram, V | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Adjepon-Yamoah, KK; Finlayson, ND; Forrest, JA; Prescott, LF | 3 |
Azarnoff, DL; Gugler, R; Lain, P | 1 |
Adjepon-Yamoah, KK; Prescott, LF; Talbot, RG | 1 |
Caccia, S; Conti, I; Duan, L; Tridico, RV | 1 |
Weiss, M | 1 |
Becker, A; Bołdys, H; Hartleb, M; Kloc, T; Mańczyk, I | 1 |
Belpaire, FM; Bogaert, MG; Chindavijak, B | 3 |
Blyden, GT; Greenblatt, DJ; LeDuc, BW; Scavone, JM | 1 |
Blyden, GT; Engelking, LR; Greenblatt, DJ; Lofstedt, J | 2 |
Ampelas, M; Côté, J; Fortunet-Fouin, H; Huet, PM; LaMarre, L; Pomier-Layrargues, G; Thibeault, MJ; Villeneuve, JP | 1 |
Michos, N; Stocker, H; Weippl, G | 1 |
Hamshaw-Thomas, A; Reynolds, F | 1 |
Adjepon-Yamoah, KK; Nimmo, J; Prescott, LF | 1 |
Branch, RA; Nies, AS; Shand, DG | 1 |
Furkert, K | 1 |
Dinnendahl, V; Kalbhen, DA | 1 |
Cheong, DK; Gangarosa, LP | 1 |
Hedges, A; Makki, KA; Perucca, E; Richens, A | 1 |
Epping, J; Fuchshofen-Röckel, M; Heusler, H; Richter, E; Zilly, W | 1 |
Ala-Kokko, TI; Herva, R; Hollmén, AI; Pelkonen, O; Pienimäki, P; Vähäkangas, K | 1 |
Ferrara, SD; Frison, G; Mazzo, M; Orlando, R; Padrini, R; Palatini, P; Tedeschi, L; Zordan, R | 1 |
Tanaka, E; Yasuhara, H | 1 |
Koester, A; Roberts, MS; Weiss, M; Wu, ZY | 1 |
Gillardin, JM; Heulard, I; Verleye, M | 1 |
Brendel, K; Mayersohn, M; Sinha, V | 1 |
Baker, AB; Gao, L; Ramzan, I | 1 |
He, J; Huang, Y; Luo, G; Miao, Z; Wang, X; Wang, Y; Wu, T; Zhao, Z | 1 |
Sagesaka, A; See, GL; Sugasawa, S; Sugibayashi, K; Todo, H | 1 |
Ba, JB; Chu, ZY; Feng, X; Liu, WH; Zhang, XD; Zou, YX | 1 |
5 review(s) available for lidocaine and antipyrine
Article | Year |
---|---|
Drug metabolism in liver disease.
Topics: Acetaminophen; Acute Disease; Antipyrine; Chemical and Drug Induced Liver Injury; Chronic Disease; Half-Life; Humans; Isoniazid; Lidocaine; Liver; Liver Diseases; Pharmaceutical Preparations; Tolbutamide | 1975 |
Hemodynamic drug interactions.
Topics: Animals; Antipyrine; Dogs; Dopamine; Drug Interactions; Enzyme Induction; Glucagon; Half-Life; Hemodynamics; Humans; Lidocaine; Liver Circulation; Macaca mulatta; Metabolic Clearance Rate; Oxyphenbutazone; Pharmaceutical Preparations; Phenobarbital; Propranolol; Time Factors | 1974 |
[Otologic agents. 13].
Topics: Adrenal Cortex Hormones; Aminopyrine; Anesthetics, Local; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Antipyrine; Benzocaine; Chloramphenicol; Disinfectants; Ear Diseases; Formaldehyde; Humans; Hydrocortisone; Lidocaine; Neomycin; Nitrofurazone; Prednisolone; Procaine; Tetracaine; Toluene | 1967 |
[Evaluation of liver function in liver diseases using drugs as indicators].
Topics: Aminopyrine; Antipyrine; Erythromycin; Humans; Lidocaine; Liver; Liver Diseases; Liver Function Tests; Trimethadione | 1997 |
Potential use of pharmacological markers to quantitatively assess liver function during liver transplantation surgery.
Topics: Adult; Antipyrine; Biomarkers; Breath Tests; Caffeine; Coloring Agents; Galactose; Humans; Indocyanine Green; Lidocaine; Liver; Liver Function Tests; Liver Transplantation; Postoperative Period; Reference Values | 2000 |
2 trial(s) available for lidocaine and antipyrine
Article | Year |
---|---|
Clinical experience and results of treatment with suprofen in pediatrics. 4th communication: Assessment of pain in babies and infants/Analgesic effect of suprofen syrup in otitis media.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Child, Preschool; Drug Combinations; Humans; Infant; Lidocaine; Otitis Media; Pain; Phenylpropionates; Solutions; Suprofen; Time Factors | 1985 |
A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs.
Topics: Adolescent; Adult; Anticonvulsants; Antipyrine; Biological Availability; Enzyme Induction; Glucaric Acid; Humans; Kinetics; Lidocaine; Middle Aged | 1980 |
47 other study(ies) available for lidocaine and antipyrine
Article | Year |
---|---|
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
Topics: 1-Octanol; Diffusion; Dimethylpolysiloxanes; Humans; In Vitro Techniques; Membranes, Artificial; Myristates; Permeability; Skin; Skin Absorption; Water | 2006 |
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.
Topics: 1-Methyl-3-isobutylxanthine; Cell Line; Cell Membrane Permeability; Humans; Models, Biological; Quantitative Structure-Activity Relationship; Skin Absorption | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.
Topics: Acetaminophen; Adult; Aged; Antipyrine; Chronic Disease; Female; Half-Life; Humans; Kinetics; Lidocaine; Liver; Liver Diseases; Male; Middle Aged; Prothrombin Time; Serum Albumin | 1977 |
Effect of portacaval shunt on the disposition of drugs with and without first-pass effect.
Topics: Animals; Antipyrine; Biological Availability; Dogs; Female; Half-Life; Kinetics; Lidocaine; Liver; Male; Portacaval Shunt, Surgical; Salicylamides; Time Factors | 1975 |
Proceedings: Antipyrine, lingocaine and paracetamol metabolism in chronic liver disease.
Topics: Acetaminophen; Adult; Aged; Antipyrine; Chronic Disease; Female; Humans; Lidocaine; Liver Diseases; Male; Middle Aged | 1975 |
Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure.
Topics: Adult; Aged; Antipyrine; Half-Life; Heart Failure; Humans; Lidocaine; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic | 1976 |
Effects of L-fenfluramine on rat liver drug-metabolizing enzymes.
Topics: Animals; Antipyrine; Cytochrome P-450 Enzyme System; Fenfluramine; Lidocaine; Liver; Male; Mixed Function Oxygenases; Rats; Rats, Inbred Strains | 1991 |
Use of metabolite AUC data in bioavailability studies to discriminate between absorption and first-pass extraction.
Topics: Absorption; Antipyrine; Biological Availability; Caffeine; Diphenhydramine; Dose-Response Relationship, Drug; Humans; Ketanserin; Lidocaine; Liver Diseases; Metronidazole; Nomifensine; Triamterene | 1990 |
[Usefulness of the evaluation of blood supply and mass of the liver for predicting the rate of pharmacokinetics of lidocaine, propranolol and phenazone].
Topics: Adult; Aged; Antipyrine; Female; Humans; Lidocaine; Liver; Liver Circulation; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Portal System; Propranolol | 1989 |
In-vitro biotransformation of antipyrine, lignocaine and propranolol in the liver of rats with turpentine-induced inflammation.
Topics: Aminopyrine N-Demethylase; Animals; Antipyrine; Biotransformation; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Hepatitis, Animal; In Vitro Techniques; Lidocaine; Liver; Male; Propranolol; Rats; Rats, Inbred Strains; Turpentine | 1987 |
Effect of inflammation and proadifen on the disposition of antipyrine, lignocaine and propranolol in rat isolated perfused liver.
Topics: Animals; Antipyrine; In Vitro Techniques; Inflammation; Lidocaine; Liver; Male; Proadifen; Propranolol; Rats; Rats, Inbred Strains; Turpentine | 1987 |
Effect of antipyrine coadministration on the kinetics of acetaminophen and lidocaine.
Topics: Acetaminophen; Adult; Antipyrine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Kinetics; Lidocaine; Male | 1988 |
Effect of inflammation on the metabolism of antipyrine, lidocaine and propranolol in isolated rat hepatocytes.
Topics: Animals; Antipyrine; Inflammation; Lidocaine; Liver; Male; Proadifen; Propranolol; Rats; Rats, Inbred Strains; Turpentine | 1988 |
Pharmacokinetics of antipyrine, acetaminophen and lidocaine in fed and fasted horses.
Topics: Acetaminophen; Animals; Antipyrine; Fasting; Female; Horses; Kinetics; Lidocaine; Liver | 1987 |
Drug disposition in patients with HBsAg-positive chronic liver disease.
Topics: Adult; Aminopyrine; Antipyrine; Female; Hepatitis; Hepatitis B Surface Antigens; Hepatitis, Chronic; Humans; Indocyanine Green; Lidocaine; Liver; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged | 1987 |
Antipyrine and lidocaine are cleared faster in horses than in humans: acetaminophen may be handled similarly.
Topics: Acetaminophen; Animals; Antipyrine; Female; Horses; Humans; Kinetics; Lidocaine; Species Specificity | 1987 |
Placental transfer of bupivacaine, pethidine and lignocaine in the rabbit. Effect of umbilical flow rate and protein content.
Topics: Animals; Antipyrine; Blood Flow Velocity; Blood Proteins; Bupivacaine; Female; Lidocaine; Maternal-Fetal Exchange; Meperidine; Perfusion; Pregnancy; Protein Binding; Rabbits; Umbilical Cord | 1985 |
Gross impairment of hepatic drug metabolism in a patient with chronic liver disease.
Topics: Adult; Antipyrine; Biotransformation; Chronic Disease; Female; Half-Life; Hepatitis; Humans; Jaundice; Lidocaine; Liver; Male | 1974 |
[Pharmacology studies on the influencing of chondroitin sulfate decomposition in vitro].
Topics: Aminopyrine; Anti-Inflammatory Agents; Antipyrine; Aspirin; Chemical Phenomena; Chemistry; Chloroquine; Chondroitin; Copper; Densitometry; Flavonoids; Flufenamic Acid; Glucosamine; Hyaluronoglucosaminidase; Iron; Lidocaine; Male; Malonates; Methylamines; Oxyphenbutazone; Prednisolone; Rutin; Sodium Chloride; Sodium Salicylate; Sulfates; Testis; Triazines | 1971 |
Local anesthetics: inhibition of subcutaneous absorption in rats.
Topics: Absorption; Animals; Antipyrine; Cocaine; Depression, Chemical; Injections, Subcutaneous; Lidocaine; Phosphates; Phosphorus Isotopes; Prilocaine; Procaine; Rats; Tetracaine | 1970 |
[Drug metabolism in patients with liver disease (author's transl)].
Topics: Acute Disease; Adult; Antipyrine; Biological Availability; Biotransformation; Cholestasis; Female; Hepatitis; Hexobarbital; Humans; Lidocaine; Liver Cirrhosis; Liver Diseases; Male; Methohexital; Middle Aged | 1980 |
Transfer of lidocaine and bupivacaine across the isolated perfused human placenta.
Topics: Anesthetics, Local; Antipyrine; Bupivacaine; Female; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Lidocaine; Maternal-Fetal Exchange; Oxygen Consumption; Partial Pressure; Placenta; Pregnancy; Reference Standards | 1995 |
Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid.
Topics: Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Humans; Hydroxybutyrates; Lidocaine; Liver Cirrhosis; Male; Middle Aged | 1996 |
Distribution kinetics of diazepam, lidocaine and antipyrine in the isolated perfused rat hindlimb.
Topics: Animals; Antipyrine; Diazepam; Hindlimb; In Vitro Techniques; Lidocaine; Male; Perfusion; Rats; Rats, Wistar; Tissue Distribution | 1997 |
Phenazone potentiates the local anaesthetic effect of lidocaine in mice.
Topics: Anesthetics, Local; Animals; Antipyrine; Dose-Response Relationship, Drug; Drug Synergism; Lidocaine; Male; Mice | 2000 |
A simplified isolated perfused rat liver apparatus: characterization and measurement of extraction ratios of selected compounds.
Topics: Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Central Nervous System Depressants; Chromatography, Gas; Chromatography, High Pressure Liquid; Ethanol; In Vitro Techniques; Lidocaine; Liver; Male; Models, Biological; Oxygen Consumption; Perfusion; Rats; Rats, Sprague-Dawley | 2000 |
The Therapeutic Effect of Stellate Ganglion Block on Facial Nerve Palsy in Patients with Type 2 Diabetes Mellitus.
Topics: Adult; Anesthetics, Local; Antipyrine; Aspirin; Autonomic Nerve Block; Blood Glucose; Dexamethasone; Diabetes Mellitus, Type 2; Edaravone; Facial Nerve Diseases; Facial Paralysis; Female; Free Radical Scavengers; Glucocorticoids; Humans; Lidocaine; Male; Middle Aged; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Prednisone; Retrospective Studies; Stellate Ganglion; Thiamine; Treatment Outcome; Vinca Alkaloids; Vitamin B 12; Vitamin B Complex | 2015 |
Eyelid skin as a potential site for drug delivery to conjunctiva and ocular tissues.
Topics: Administration, Cutaneous; Aminopyrine; Animals; Antipyrine; Diclofenac; Eye; Lidocaine; ortho-Aminobenzoates; Permeability; Pilocarpine; Rats, Hairless; Rhodamines; Skin; Skin Absorption | 2017 |
Preclinical safety assessment of antipyrine combined with lidocaine hydrochloride as ear drops.
Topics: Animals; Antipyrine; Dose-Response Relationship, Drug; Drug Combinations; Ear; Erythrocytes; Female; Gastrointestinal Tract; Guinea Pigs; Lidocaine; Liver; Male; Mice; Mice, Inbred ICR; Pharmaceutical Solutions; Rabbits; Rats; Rats, Sprague-Dawley | 2019 |